Applied Physiology Laboratory
Chapel Hill, North Carolina, 27599, United States
Location status: Recruiting
Location contact
Abbie Smith-Ryan, PhD
PRINCIPAL_INVESTIGATOR
Research Coordinator
CONTACT
NCT Number: NCT07792603
This study evaluates the acute and chronic effects of an essential amino acid supplement (Daily Upgrade EAA+) on metabolomics, amino acid kinetics, metabolic rate, body composition in active adult women. The study consists of an acute randomized double-blind crossover phase comparing EAA+, whey protein isolate, and placebo before high-intensity interval training (HIIT), and a chronic randomized double-blind parallel-arm phase evaluating 3 weeks of EAA+ or placebo supplementation combined with twice-weekly HIIT.
Interested in participating?
Request Info25 year–45 year
Female
Interventional
Not applicable
Chapel Hill, North Carolina, 27599, United States
Location status: Recruiting
Abbie Smith-Ryan, PhD
PRINCIPAL_INVESTIGATOR
Research Coordinator
CONTACT
The trial includes an acute crossover phase and a chronic parallel-group phase. In the acute phase, participants complete three randomized laboratory visits during which they consume Daily Upgrade EAA+, whey protein isolate, or a non-caloric placebo prior to a standardized high-intensity interval training (HIIT) session. Metabolomic responses, amino acid kinetics, metabolic outcomes are assessed before and after exercise.
In the chronic phase, participants are randomized to consume Daily Upgrade EAA+ or placebo daily for three weeks while completing supervised HIIT sessions twice per week. Outcomes assessed before and after the intervention include body composition, exercise performance, fluid balance, and gastrointestinal symptoms.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Daily supplementation of essential amino acids
Daily supplementation with non-caloric placebo
Twice weekly high intensity interval training for 3 weeks
No exercise
Time frame: Baseline, 30, 60, and 90 minutes following supplementation during acute visits.
Area under the curve for metabolomic responses
Time frame: Before (0 min) and after (30, 60, 90 min) one session of high intensity interval training
Respiratory exchange ratio (RER)
Time frame: Baseline and week 4
Dual energy x-ray absorptiometry-derived lean soft tissue
Time frame: Baseline week 4
Muscle cross sectional area derived from peripheral quantitative computed tomography
Time frame: Baseline, week 1, week 2, week 3, week 4
Total body water
Time frame: Baseline and week 4
Near infrared spectroscopy
Time frame: Baseline, week 4
Questionnaire derived mood and fatigue from patient-reported outcomes measurement information system (PROMIS), score range 30-60, with higher scores representing worse mood.
Time frame: Baseline, week 4
Skin texture measured from the patient reported outcome measure, scored from 0 (lowest satisfaction/worst outcome) to 100 (highest satisfaction/best outcome).
Contact information is provided by the study sponsor or research team.
Abbie Smith-Ryan, PhD
CONTACT
Research Coordinator
CONTACT
University of North Carolina, Chapel Hill
Other
TONE UP: Daily Upgrade Trial: Tone, Oxygenation, Neuromood, Energy - Upgrade Evaluation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07439458
Acute Exercise, Breast Cancer Cell Lines
Riga, Dzirciema Street 16, Latvia
View Trial DetailsNCT06746220
Behavior, Healthy Women
Orléans, France
View Trial DetailsNCT06985420
Healthy Women, Menstruation
Orlando, Florida, United States
View Trial DetailsNCT07793123
Healthy Women
Paris, France
View Trial Details